Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900025283Phase 4Recruiting
Phase 4, randomised, double-blind trial of prednisone and liushenwan in nonsuppurative thyroiditis (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Recurrence rate. Started Oct 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900025283.